Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 30 July 2012 | By Ansis Helmanis,
Brazilian consumers will not be able to purchase over-the-counter drug products at pharmacies according to new rules published 17 July 2012 by Brazilian health regulator Anvisa.
Under the new rules, the OTC products may be purchased in a manner similar to cosmetics and dietary supplements,regulators explained.
OTC drugs must be organized on pharmacy shelves by active ingredient with the cautionary statement that drugs may cause unwanted side effects. Anvisa opened a public consultation in April 2012 that led to the reversal of a 2009 decision restricting OTC drugs to being kept behind the counter.
Read more:
Anvisa - OTC medications may be within reach of the consumer
Read all Breaking News from RegLink
Tags: Over-the-counter, OTC, Consumers, brazil